In March 2025, Coordination Pharmaceuticals Inc. announced a phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or ...

squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Receive News & Ratings for Janux Therapeutics Daily - Enter your email address below to receive ...

Issuing a draft list of revised risk-based classification of cardiovascular and neurological devices, the Central Drugs ...

squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Receive News & Ratings for Janux Therapeutics Daily - Enter your email address below to receive ...

med.cornell.edu Carotid blowout syndrome (CBS) is a high-risk condition associated with significant morbidity and mortality that may result from invasion and destruction of the cervical carotid ...

In March 1970, neurosurgeon Dr. Robert J. White performed the first cephalic transplant on two rhesus monkeys. Jenna El-Attar/ Guest Artist The scene is like any ordinary operating room. The ...

Many symptoms of head and neck cancer are hard to miss—a lump in the neck, persistent hoarseness, a mouth sore that doesn't ...

April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC). The research identified enolase 2 (ENO2), a ...

Head and neck cancer comprises a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx and larynx.